Rallye in Biontech shares extends as European Medicines Agency has accelerated approval process for a Covid-19 vaccine developed by Germany's BioNTech & Pfizer, to allow for the rapid authorisation of the shot as soon as safety data from its trial allows. #CoronavirusOutbreak# #Eurozone# #StockMarket#
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.